Lalitha M Vakkalanka, MD
Internal Medicine · Gilroy
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Bay Area Community Health · 106 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Vakkalanka’s office at (408) 729-9700 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$1,612
Medicare paid this office $1,612 for 31 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (30+ min) | 26 | $975 | $38 |
Who their Medicare patients are
31 Original Medicare patients in 2024. Average age 68 · Women 65% · Also on Medicaid 45% · Health risk score 1.18. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 68%.
The office billed $24,267, Medicare allowed $4,246 and paid $1,612; for 46 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 31 | 46 | 68 | 1.18 | $24,267 | $1,612 |
| 2023 | 88 | 122 | 70 | 1.73 | $80,930 | $13,302 |
| 2017 | 15 | 20 | 65 | 0.79 | $416 | $154 |
| 2016 | 17 | 24 | 72 | 0.88 | $1,105 | $506 |
| 2014 | 155 | 301 | 71 | 0.75 | $24,653 | $18,279 |
| 2013 | 339 | 1,746 | 71 | 1.17 | $188,078 | $61,463 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Residence visit for new patient with high level of medical decision making, per day at least 75 minutes | 43 | $7,002 | $163 |
| New patient visit (30+ min) | 37 | $3,507 | $92 |
2017: 1 service
| Urinalysis, manual test | 14 | $65 | $3 |
2016: 1 service
| Urinalysis, manual test | 13 | $61 | $3 |
2014: 4 services
| Return visit (30+ min) | 97 | $11,478 | $84 |
| New patient visit (30+ min) | 44 | $3,460 | $79 |
| Short return visit (20+ min) | 16 | $1,013 | $60 |
| Manual urinalysis test with examination using microscope, non-automated | 17 | $89 | $4 |
2013: 14 services
| Short return visit (20+ min) | 202 | $20,864 | $51 |
| Return visit (30+ min) | 156 | $13,552 | $71 |
| New patient visit (45+ min) | 62 | $5,901 | $95 |
| Short return visit | 83 | $3,696 | $29 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $3,400 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,482 | $78 |
| New patient visit (30+ min) | 35 | $1,161 | $33 |
| Hospital discharge day management, 30 minutes or less | 11 | $598 | $54 |
| Administration of influenza virus vaccine | 14 | $343 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $222 | $12 |
| X-ray of chest, 2 views, front and side | 15 | $215 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 18 | $144 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 21 | $138 | $6 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 13 | $124 | $10 |
Medicaid work
$144,448 in 2024
Medicaid paid $144,448 for 1,753 billed services this clinician did in 2024, up to 139 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 422 | $120,001 |
| New patient visit (30+ min) | 285 | $13,234 |
| Short return visit (20+ min) | 540 | $6,094 |
| Return visit (30+ min) | 406 | $4,221 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 17 | $422 |
| SARSCOV CORONAVIRUS AG IA | 14 | $194 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 43 | $190 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 26 | $92 |
| 2024 | 1,753 | 8 | 139 | $144,448 |
| 2023 | 354 | 5 | 92 | $12,278 |
| 2021 | 3,344 | 9 | 91 | $77,027 |
| 2020 | 4,369 | 11 | 78 | $102,114 |
| 2019 | 1,550 | 9 | 88 | $42,375 |
| 2018 | 12 | 1 | 12 | $1 |
See the largest Medicaid services in earlier years
2023
| New patient visit (30+ min) | 266 | $11,355 |
| Short return visit (20+ min) | 17 | $331 |
| SARSCOV CORONAVIRUS AG IA | 17 | $304 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 32 | $188 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 22 | $101 |
2021
| Clinic visit/encounter, all-inclusive | 616 | $76,931 |
| Short return visit (20+ min) | 784 | $96 |
| Medication list documented in medical record (COA) | 428 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 428 | $0 |
| FXNL STATUS ASSESSED | 211 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 310 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 311 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 27 | $0 |
| Return visit (30+ min) | 229 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 827 | $102,066 |
| Short return visit (20+ min) | 1,094 | $48 |
| Medication list documented in medical record (COA) | 593 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 593 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 454 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 49 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 482 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 89 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 12 | $0 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use | 12 | $0 |
| Return visit (30+ min) | 164 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 340 | $41,406 |
| Short return visit (20+ min) | 663 | $737 |
| Return visit (30+ min) | 118 | $186 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 23 | $46 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 147 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 31 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 151 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 40 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 37 | $0 |
2018
| BODY MASS INDEX DOCD | 12 | $1 |
Drugs they prescribed that Part D paid
$21,340
Pharmacies billed $21,340 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 198) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
171 generic and 27 brand-name prescriptions · $21,340 in drug cost · 21 antibiotic prescriptions to 19 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 14 | $180 | $7 |
| Metformin | 11 | $166 | $6 |
Year by year
| 2024 | 198 | 73 | 0% (0) | 14% | $21,340 |
| 2023 | 272 | 51 | None | 9% | $14,560 |
| 2022 | 38 | 15 | 0% (0) | None | $2,913 |
| 2021 | 719 | 79 | 0% (0) | 17% | $77,188 |
| 2020 | 846 | 91 | 0% (0) | 22% | $85,377 |
| 2019 | 266 | 62 | 0% (0) | None | $21,086 |
| 2018 | 323 | 97 | 0% (0) | None | $12,504 |
| 2017 | 1,254 | 172 | 0% (0) | None | $38,803 |
| 2016 | 1,583 | 217 | None | 14% | $55,534 |
| 2015 | 693 | 131 | None | 13% | $22,155 |
| 2014 | 595 | 183 | 2% (12) | None | $28,414 |
| 2013 | 1,569 | 211 | 4% (56) | 20% | $83,499 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Levothyroxine | 27 | $337 | $12 |
| Omeprazole | 14 | $174 | $12 |
| Atorvastatin | 16 | $131 | $8 |
| Metformin | 14 | $71 | $5 |
| Furosemide | 14 | $62 | $4 |
2021: 19 drugs
| Flovent Hfa | 11 | $3,220 | $293 |
| Levothyroxine | 61 | $1,339 | $22 |
| Albuterol Sulfate Hfa | 14 | $662 | $47 |
| Metoprolol | 22 | $368 | $17 |
| Omeprazole | 24 | $343 | $14 |
| Metformin | 45 | $317 | $7 |
| Atorvastatin | 40 | $315 | $8 |
| Diclofenac | 13 | $233 | $18 |
| Amlodipine Besylate | 29 | $217 | $7 |
| Gabapentin | 25 | $184 | $7 |
| Hydrochlorothiazide | 35 | $181 | $5 |
| Lisinopril | 34 | $175 | $5 |
| Montelukast | 12 | $163 | $14 |
| Ibuprofen | 20 | $141 | $7 |
| Glipizide | 22 | $119 | $5 |
| Gemfibrozil | 13 | $113 | $9 |
| Alendronate | 11 | $88 | $8 |
| Metoprolol | 14 | $74 | $5 |
| Losartan | 14 | $51 | $4 |
2020: 23 drugs
| Januvia | 12 | $13,937 | $1,161 |
| Novolin 70-30 | 12 | $8,847 | $737 |
| Lantus Solostar | 12 | $6,711 | $559 |
| Advair Hfa | 11 | $3,604 | $328 |
| Betamethasone Diprop Augmented | 11 | $2,349 | $214 |
| Levothyroxine | 77 | $1,674 | $22 |
| Ventolin Hfa | 12 | $688 | $57 |
| Atorvastatin | 63 | $641 | $10 |
| Metoprolol | 16 | $372 | $23 |
| Metformin | 47 | $355 | $8 |
| Omeprazole | 28 | $328 | $12 |
| Gabapentin | 24 | $224 | $9 |
| Gemfibrozil | 17 | $182 | $11 |
| Losartan | 19 | $177 | $9 |
| Lisinopril | 38 | $175 | $5 |
| Hydrochlorothiazide | 33 | $170 | $5 |
| Ibuprofen | 32 | $162 | $5 |
| Triamcinolone Acetonide | 19 | $142 | $7 |
| Glipizide | 20 | $123 | $6 |
| Montelukast | 14 | $121 | $9 |
| Amlodipine Besylate | 30 | $118 | $4 |
| Alendronate | 17 | $118 | $7 |
| Sertraline | 16 | $40 | $2 |
2019: 7 drugs
| Levothyroxine | 15 | $240 | $16 |
| Atorvastatin | 20 | $212 | $11 |
| Glipizide | 19 | $193 | $10 |
| Metformin | 18 | $192 | $11 |
| Losartan | 11 | $108 | $10 |
| Amlodipine Besylate | 14 | $79 | $6 |
| Lisinopril | 12 | $43 | $4 |
2018: 9 drugs
| Levothyroxine | 14 | $260 | $19 |
| Lisinopril | 29 | $250 | $9 |
| Metformin | 50 | $223 | $4 |
| Glimepiride | 12 | $176 | $15 |
| Losartan | 23 | $159 | $7 |
| Amlodipine Besylate | 21 | $155 | $7 |
| Omeprazole | 14 | $136 | $10 |
| Hydrochlorothiazide | 13 | $88 | $7 |
| Simvastatin | 14 | $58 | $4 |
2017: 25 drugs
| Lantus | 29 | $10,367 | $357 |
| Ventolin Hfa | 29 | $2,238 | $77 |
| Levothyroxine | 101 | $1,861 | $18 |
| Metformin | 195 | $935 | $5 |
| Omeprazole | 67 | $574 | $9 |
| Lisinopril | 108 | $543 | $5 |
| Hydrochlorothiazide | 58 | $403 | $7 |
| Glimepiride | 37 | $378 | $10 |
| Propranolol | 11 | $310 | $28 |
| Amoxicillin-Clavulanate Potass | 23 | $295 | $13 |
| Amlodipine Besylate | 54 | $264 | $5 |
| Losartan | 59 | $244 | $4 |
| Glipizide | 38 | $212 | $6 |
| Metoprolol | 38 | $166 | $4 |
| Simvastatin | 22 | $130 | $6 |
| Atorvastatin | 12 | $130 | $11 |
| Carvedilol | 26 | $129 | $5 |
| Lisinopril-Hydrochlorothiazide | 21 | $110 | $5 |
| Atenolol | 24 | $101 | $4 |
| Ciprofloxacin | 14 | $91 | $7 |
| Losartan-Hydrochlorothiazide | 13 | $88 | $7 |
| Metformin Hcl Er | 18 | $73 | $4 |
| Ibuprofen | 14 | $71 | $5 |
| Furosemide | 18 | $57 | $3 |
| Ramipril | 12 | $41 | $3 |
2016: 31 drugs
| Lantus | 42 | $12,104 | $288 |
| Humalog | 18 | $4,561 | $253 |
| Levothyroxine | 113 | $1,963 | $17 |
| Metformin | 196 | $1,194 | $6 |
| Ventolin Hfa | 18 | $942 | $52 |
| Tamsulosin | 14 | $847 | $60 |
| Hydrochlorothiazide | 95 | $800 | $8 |
| Lisinopril | 131 | $660 | $5 |
| Glimepiride | 75 | $508 | $7 |
| Omeprazole | 61 | $507 | $8 |
| Amlodipine Besylate | 85 | $384 | $5 |
| Gabapentin | 24 | $329 | $14 |
| Glipizide | 39 | $304 | $8 |
| Amoxicillin-Clavulanate Potass | 16 | $235 | $15 |
| Carvedilol | 43 | $232 | $5 |
| Simvastatin | 37 | $214 | $6 |
| Losartan | 56 | $207 | $4 |
| Atorvastatin | 15 | $172 | $11 |
| Metoprolol | 37 | $159 | $4 |
| Ibuprofen | 19 | $155 | $8 |
| Losartan-Hydrochlorothiazide | 18 | $147 | $8 |
| Ciprofloxacin | 17 | $124 | $7 |
| Benazepril | 20 | $114 | $6 |
| Lisinopril-Hydrochlorothiazide | 32 | $108 | $3 |
| Ramipril | 12 | $90 | $7 |
| Hydralazine | 11 | $89 | $8 |
| Atenolol | 18 | $84 | $5 |
| Clopidogrel | 15 | $73 | $5 |
| Furosemide | 22 | $70 | $3 |
| Alendronate | 12 | $46 | $4 |
| Metformin Hcl Er | 18 | $45 | $2 |
2015: 19 drugs
| Lantus | 16 | $4,291 | $268 |
| Proair Hfa | 19 | $1,023 | $54 |
| Tamsulosin | 18 | $936 | $52 |
| Levothyroxine | 20 | $451 | $23 |
| Metformin | 74 | $426 | $6 |
| Lisinopril | 72 | $393 | $5 |
| Glimepiride | 33 | $252 | $8 |
| Hydrochlorothiazide | 34 | $233 | $7 |
| Warfarin | 22 | $202 | $9 |
| Amlodipine Besylate | 33 | $180 | $5 |
| Glipizide | 12 | $137 | $11 |
| Metoprolol | 18 | $126 | $7 |
| Losartan | 23 | $114 | $5 |
| Atorvastatin | 12 | $109 | $9 |
| Omeprazole | 13 | $90 | $7 |
| Clopidogrel | 12 | $83 | $7 |
| Gabapentin | 14 | $82 | $6 |
| Simvastatin | 22 | $71 | $3 |
| Lisinopril-Hydrochlorothiazide | 13 | $54 | $4 |
2014: 14 drugs
| Proair Hfa | 11 | $923 | $84 |
| Levothyroxine | 35 | $551 | $16 |
| Atorvastatin | 18 | $372 | $21 |
| Lisinopril | 43 | $255 | $6 |
| Metformin | 29 | $244 | $8 |
| Gabapentin | 17 | $203 | $12 |
| Amox Tr-Potassium Clavulanate | 13 | $187 | $14 |
| Omeprazole | 11 | $169 | $15 |
| Amlodipine Besylate | 16 | $151 | $9 |
| Hydrochlorothiazide | 22 | $132 | $6 |
| Simvastatin | 13 | $123 | $9 |
| Carvedilol | 13 | $108 | $8 |
| Atenolol | 14 | $68 | $5 |
| Furosemide | 13 | $34 | $3 |
2013: 38 drugs
| Symbicort | 26 | $6,272 | $241 |
| Advair Diskus | 13 | $4,632 | $356 |
| Omeprazole | 55 | $1,140 | $21 |
| Escitalopram | 21 | $920 | $44 |
| Levothyroxine | 67 | $810 | $12 |
| Atorvastatin | 24 | $773 | $32 |
| Proair Hfa | 12 | $643 | $54 |
| Metoprolol | 14 | $637 | $46 |
| Losartan | 37 | $623 | $17 |
| Lisinopril | 86 | $566 | $7 |
| Clopidogrel | 14 | $559 | $40 |
| Hydrochlorothiazide | 64 | $550 | $9 |
| Metformin | 47 | $485 | $10 |
| Simvastatin | 42 | $472 | $11 |
| Gabapentin | 14 | $431 | $31 |
| Amlodipine Besylate | 44 | $405 | $9 |
| Diltiazem 24hr Er | 14 | $396 | $28 |
| Metoprolol | 47 | $347 | $7 |
| Amox Tr-Potassium Clavulanate | 16 | $328 | $21 |
| Warfarin | 32 | $302 | $9 |
| Gemfibrozil | 16 | $285 | $18 |
| Sertraline | 20 | $283 | $14 |
| Pantoprazole | 27 | $271 | $10 |
| Glyburide | 17 | $261 | $15 |
| Carvedilol | 32 | $254 | $8 |
| Digox | 14 | $210 | $15 |
| Hydrocodone-Acetaminophen | 18 | $188 | $10 |
| Tramadol | 31 | $183 | $6 |
| Sumatriptan | 12 | $167 | $14 |
| Fluoxetine | 24 | $163 | $7 |
| Lamotrigine | 18 | $152 | $8 |
| Tamsulosin | 12 | $134 | $11 |
| Ciprofloxacin | 16 | $117 | $7 |
| Atenolol | 25 | $116 | $5 |
| Furosemide | 22 | $96 | $4 |
| Clonidine | 12 | $93 | $8 |
| Ranitidine | 14 | $72 | $5 |
| Trazodone | 12 | $60 | $5 |
Money from drug and device companies
$41 in 2024
| 2024 | 1 | 2 | None | $41 |
| 2023 | 1 | 1 | None | $18 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exact Sciences | Cologuard Collection Kit | $41 | 2 payments
|
See all 2 published payments
| Exact Sciences | Meals · 2024-11-18 | Cologuard Collection Kit | $20 |
| Exact Sciences | Meals · 2024-09-10 | Cologuard Collection Kit | $21 |
See earlier years (2023)
2023: $18
| Idorsia Pharmaceuticals US | Quviviq | $18 | 1 payment
|
Professional record
- NPI
- 1194755959
- Licence
- CA A053202
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 140 E Commonwealth Ave Ste 100, Fullerton, CA, 92832
- NPI first listed
- 2006-07-04
- NPI last updated
- 2023-03-24
- NPI record certified
- 2023-03-24
This is when the NPI record was last certified, not a medical board exam.